Explore / Clinical trial
Clinical trial

Ketamine's Efficiency in the Treatment of Chronic Pain: Kynurenin Pathway

RedarUnknownPhase 3Started Feb 16, 201848 enrolledFranceNCT03513822

Abstract

The kynurenine pathway is involved in hyperalgesia. This pathway is activated by inflammation. Ketamine would interact with the kynurenine pathway and inflammation. Our working hypotheses are: the clinical effects of ketamine on neuropathic pain are greater in the presence of systemic inflammation and the mechanism of action involves an interaction on the kynurenine pathway. Study design: Interventional randomized placebo-controlled clinical trial. Main goals: 1. To show a better clinical efficacy of ketamine in chronic pain in patients with an inflammatory component. 2. Explore the anti-inflammatory activity of ketamine through the Kynurenine pathway.

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

KetaminePain

Keywords

CHRONIC PAINNEUROPATHIC PAINKYNURENINEKYNURENINE PATHWAYBEDSORESANTI-INFLAMMATORYULCER PRESSURENeuralgiaChronic PainInflammation

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.